| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.30B | 18.91B | 17.98B | 16.12B | 14.33B | 13.54B |
| Gross Profit | 9.97B | 9.53B | 9.15B | 8.34B | 7.69B | 7.83B |
| EBITDA | 5.35B | 5.04B | 4.79B | 3.76B | 4.32B | 3.72B |
| Net Income | 3.90B | 3.56B | 3.40B | 2.56B | 3.15B | 2.76B |
Balance Sheet | ||||||
| Total Assets | 184.45B | 190.90B | 181.40B | 175.19B | 158.85B | 175.91B |
| Cash, Cash Equivalents and Short-Term Investments | 8.34B | 10.10B | 60.67B | 59.13B | 47.91B | 39.30B |
| Total Debt | 3.28B | 5.86B | 5.47B | 5.75B | 5.38B | 5.20B |
| Total Liabilities | 178.24B | 184.35B | 176.18B | 170.46B | 155.05B | 169.97B |
| Stockholders Equity | 6.21B | 6.55B | 5.23B | 4.73B | 3.80B | 5.94B |
Cash Flow | ||||||
| Free Cash Flow | 1.67B | 2.89B | 6.42B | 4.50B | 4.22B | 3.21B |
| Operating Cash Flow | 1.67B | 2.89B | 6.59B | 4.68B | 4.41B | 3.33B |
| Investing Cash Flow | 422.00M | -650.00M | -551.00M | -9.26B | -13.58B | -4.38B |
| Financing Cash Flow | -3.14B | -2.08B | -5.17B | 4.41B | 8.43B | 1.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $42.55B | 11.53 | 11.09% | 2.43% | 1.43% | 10.86% | |
73 Outperform | $42.36B | 11.33 | 61.59% | 1.26% | 6.43% | 36.14% | |
73 Outperform | $30.58B | 12.32 | 14.45% | 2.21% | -5.75% | -10.69% | |
70 Outperform | $142.71B | 34.66 | 36.16% | 3.02% | 17.79% | 17.92% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $93.75B | 12.56 | 13.48% | 1.71% | 1.91% | 31.72% | |
58 Neutral | $16.77B | ― | 9.65% | 2.30% | -26.37% | -49.86% |